Goldman Sachs Reiterates Sell on Dolby Laboratories (DLB)

Goldman Sachs is out with its report on Dolby Laboratories DLB, reiterating Sell. In a note to clients, Goldman Sachs writes, "We reiterate our Sell rating on Dolby shares as we believe the company is transitioning from a high growth company, growing EPS at 30% plus rates, to a company that will grow slightly better than the overall market, implying it should trade closer to market multiples." Shares of DLB closed Wednesday at $49.87, down 0.80% from Tuesday's close.